Nektar Therapeutics (NKTR)

Last Closing Price: 34.42 (2026-11-18)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Nektar Therapeutics (NKTR) had Net Income of $-55.65M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$9.39M
Net Income
$-55.65M
--
$9.39M
$67.19M
$-57.80M
$2.76M
$-55.05M
$-55.05M
$-55.07M
$-55.65M
$-55.65M
$-55.07M
$-57.80M
$-61.16M
34.18M
34.18M
$-1.63
$-1.63
Balance Sheet Financials
$679.33M
--
$357.92M
$1.04B
$75.48M
--
$112.05M
$187.53M
$849.72M
$849.72M
$849.72M
34.21M
Cash Flow Statement Financials
$-192.00M
$-683.00M
$894.57M
$15.12M
$34.69M
$19.57M
$10.47M
--
--
Fundamental Metrics & Ratios
9.00
--
--
--
--
100.00%
-615.83%
-615.83%
--
-586.47%
-592.91%
$-192.51M
--
--
--
0.01
--
--
--
-6.55%
-6.55%
-5.37%
-6.55%
$24.84
$-5.63
$-5.62